Health & Environmental Research Online (HERO)


Print Feedback Export to File
1235922 
Journal Article 
Chromium(V) is produced upon reduction of chromate by mitochondrial electron transport chain complexes 
Rossi, SC; Wetterhahn, KE 
1989 
Yes 
Carcinogenesis
ISSN: 0143-3334
EISSN: 1460-2180 
10 
913-920 
English 
Incubation of chromate with isolated rat liver submitochondrial particles under anaerobic conditions in vitro results in reduction of chromium(VI) and formation of chromium(V). In the presence of NADH, submitochondrial particles (SMPs) were active in reducing chromate as shown by UV-vis spectroscopic studies, and forming a chromium(V) species which was detectable by electron paramagnetic resonance spectroscopy. In the presence of succinate, SMPs were less effective in reducing chromate and forming chromium(V) relative to their NADH-dependent activity. However, SMPs showed a higher rate of oxygen depletion with NADH as compared to succinate as substrate, suggesting that differences in the NADH-dependent versus succinate-dependent chromate-reductase activity of SMPs is probably due to differences in efficiency of electron donation by succinate and NADH. The use of specific electron transport chain inhibitors allowed the sites of chromium(VI) reduction and chromium(V) formation in SMPs to be determined. Rotenone, antimycin and cyanide all produced approximately 40% inhibition of the NADH-dependent chromate-reductase activity. Thus, complex I (NADH:ubiquinone oxidoreductase) appears to be responsible for the inhibitor-insensitive, and complex IV (ferrocytochrome c:oxygen oxidoreductase) for the inhibitor-sensitive NADH-dependent chromium(VI) reduction and chromium(V) formation. Cyanide and antimycin produced approximately 50% inhibition of the succinate-dependent chromate-reductase activity of SMPs, while no detectable inhibition was observed with rotenone. These results confirm the chromate-reductase activity of complex IV, and suggest that complex II (succinate:ubiquinone oxidoreductase) is responsible for the inhibitor-insensitive succinate-dependent chromate-reductase activity of SMPs. Since chromium(VI) is effectively metabolized by electron transport chain complexes of the mitochondrial inner membrane in vitro, and chromium(V) is formed as an intermediate in the process, mitochondria may play a role in chromium(VI) carcinogenesis. 
NUCLEIC ACIDS; PURINES; PYRIMIDINES; AMINO ACIDS; PEPTIDES; PROTEINS; MINERALS; BIOPHYSICS/METHODS; BIOPHYSICS; ELECTRON TRANSPORT; ENERGY METABOLISM; OXIDATIVE PHOSPHORYLATION; COENZYMES; COMPARATIVE STUDY; ENZYMES; ENZYMES/PHYSIOLOGY; MINERALS/METABOLISM; POISONING; ANIMALS, LABORATORY; CARCINOGENS; MURIDAE; Biochemical Studies-Nucleic Acids; Biochemical Studies-Proteins; Biochemical Studies-Minerals; Biophysics-General Biophysical Techniques; Biophysics-Bioenergetics: Electron Transport and Oxidative Phosphorylation; KW - Enzymes-General and Comparative Studies; Enzymes-Physiological Studies; Metabolism-Minerals; Toxicology-General; Neoplasms and Neoplastic Agents-Carcinogens and Carcinogenesis; 18540-29-9 
IRIS
• Chromium VI
     Considered
          Potentially Relevant Supplemental Material
               ADME